Pneumatic Retinopexy in Patients with Primary Rhegmatogenous Retinal Detachment Meeting PIVOT Trial Criteria

被引:15
|
作者
Juncal, Verena R. [1 ,2 ]
Bamakrid, Motaz [2 ]
Jin, Shicheng [3 ]
Paracha, Quratulain [2 ]
Kim, David T. Ta [1 ,2 ]
Marafon, Samara B. [1 ,2 ]
Francisconi, Carolina L. M. [4 ]
Muni, Rajeev H. [1 ,2 ,5 ,6 ]
机构
[1] Univ Toronto, Dept Ophthalmol & Vis Sci, Toronto, ON, Canada
[2] St Michaels Hosp, Unity Hlth Toronto, Dept Ophthalmol, Toronto, ON, Canada
[3] Univ Toronto, Fac Med, Toronto, ON, Canada
[4] Dalhousie Univ, Dept Ophthalmol & Visual Sci, Halifax, NS, Canada
[5] Hosp Sick Children, Dept Ophthalmol, Toronto, ON, Canada
[6] Kensington Vis & Res Ctr, Toronto, ON, Canada
来源
OPHTHALMOLOGY RETINA | 2021年 / 5卷 / 03期
关键词
FOLLOW-UP; REPAIR;
D O I
10.1016/j.oret.2020.07.022
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To identify the proportion of patients with primary rhegmatogenous retinal detachment (RRD) presenting to a retina practice that meet 'Pneumatic Retinopexy versus Vitrectomy for the Management of Primary RRD' (PIVOT) trial criteria and to assess anatomic and functional outcomes of pneumatic retinopexy (PnR) in this population. Design: Retrospective consecutive case series. Participants: Patients with primary RRD treated between October 2009 and November 2017 at an academic vitreoretinal practice in Canada. Methods: Medical records of all cases >18 years old with primary RRD were reviewed and the proportion of patients meeting PIVOT criteria was determined. Patients that met PIVOT criteria who underwent PnR with a follow-up >3 months were included for further analysis. Main Outcome Measures: The primary outcome was the primary retinal reattachment rate at 12 months among patients meeting PIVOT criteria undergoing PnR. Results: A total of 1,091 patients were identified, of which 577 (52.9%) met PIVOT criteria. Of these, 482/577 (83.5%) underwent PnR, but 54/482 (11.2%) were excluded as these had been enrolled in the PIVOT trial, and another 40/482 (8.3%) were excluded due to short follow-up (<3 months). Therefore, data pertaining to 388 patients is included in our analysis. 79.4% (308/388), 78.2% (280/358), 76.5% (241/315) and 73.9% (178/241) of patients who followed up at 3, 6, 12, and 24 months, respectively, had primary anatomic reattachment. A total of 20.6% (80/388) of patients did not reattach with the initial PnR or re-detached in the early post-procedure period (3 months), 2.1% (8/388) of patients re-detached between 3-12 months, and 1.3% (5/388) re-detached after 1 year. Phakic lens status was the only significant predictor of PnR success at 12 months in a multivariate logistic regression analysis (P = 0.006). Mean logMAR VA improved from 0.90 +/- 0.90 (Snellen 20/159) at baseline t 0.34 +/- 0.40 (Snellen 20/44) at 12 months (P < 0.001). Conclusions: Over 50% of patients presenting to an academic tertiary retina practice with primary RRD met PIVOT criteria and were eligible for PnR. Evidence from this study demonstrates a durable primary anatomic retinal reattachment rate with PnR in patients fulfilling PIVOT criteria, with similar results to those encountered in the PIVOT trial. (C) 2020 by the American Academy of Ophthalmology
引用
收藏
页码:262 / 269
页数:8
相关论文
共 50 条
  • [1] The Pneumatic Retinopexy versus Vitrectomy for the Management of Primary Rhegmatogenous Retinal Detachment Outcomes Randomized Trial (PIVOT)
    Hillier, Roxane J.
    Felfeli, Tina
    Berger, Alan R.
    Wong, David T.
    Altomare, Filiberto
    Dai, David
    Giavedoni, Louis R.
    Kertes, Peter J.
    Kohly, Radha P.
    Muni, Rajeev H.
    OPHTHALMOLOGY, 2019, 126 (04) : 531 - 539
  • [2] Real-World Evidence of Anatomical Success Rates and Visual Acuity Outcomes of Pneumatic Retinopexy in Patients with Primary Rhegmatogenous Retinal Detachment meeting PIVOT Trial Criteria
    Muni, Rajeev Hemant
    Bamakrid, Motaz
    Paracha, Quratulain
    Jin, Shicheng
    Francisconi, Carolina
    Juncal, Verena
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [3] Pneumatic retinopexy in the treatment of primary rhegmatogenous retinal detachment
    Assi, AC
    Charteris, DG
    Pearson, RV
    Gregor, ZJ
    EYE, 1999, 13 (6) : 725 - 728
  • [4] Infographic: the Pneumatic Retinopexy versus Vitrectomy for the Management of Primary Rhegmatogenous Retinal Detachment Outcomes Randomized Trial (PIVOT)
    Murphy, Declan C.
    Tzoumas, Nikolaos
    Mehta, Alex
    Mostafa, Islam
    Sadiq, Salman N.
    Song, Anna
    Al-Zubaidy, Mo
    Ghareeb, Ali E.
    Steel, David H.
    EYE, 2022, 36 (05) : 913 - 914
  • [5] Infographic: the Pneumatic Retinopexy versus Vitrectomy for the Management of Primary Rhegmatogenous Retinal Detachment Outcomes Randomized Trial (PIVOT)
    Declan C. Murphy
    Nikolaos Tzoumas
    Alex Mehta
    Islam Mostafa
    Salman N. Sadiq
    Anna Song
    Mo Al-Zubaidy
    Ali E. Ghareeb
    David H. Steel
    Eye, 2022, 36 : 913 - 914
  • [6] Pneumatic retinopexy in the treatment of primary rhegmatogenous retinal detachment
    A C Assi
    D G Charteris
    R V Pearson
    Z J Gregor
    Eye, 1999, 13 : 725 - 728
  • [7] Pneumatic retinopexy for rhegmatogenous retinal detachment in elderly patients
    Schutz, James S.
    OPHTHALMOLOGY RETINA, 2024, 8 (04): : e13 - e13
  • [8] Pneumatic Retinopexy for Rhegmatogenous Retinal Detachment in Elderly Patients
    Shor, Reut
    Melo, Isabela Martins
    Motekalem, Yasmin
    Zajner, Chris
    Muni, Rajeev H.
    OPHTHALMOLOGY RETINA, 2023, 7 (11): : 959 - 964
  • [9] Reassessment of pneumatic retinopexy for primary treatment of rhegmatogenous retinal detachment
    Cohen, Eyal
    Zerach, Amir
    Mimouni, Michael
    Barak, Adiel
    CLINICAL OPHTHALMOLOGY, 2015, 9 : 2033 - 2037
  • [10] Review and analysis of history and utilization of pneumatic retinopexy after pneumatic retinopexy versus vitrectomy for the management of primary rhegmatogenous retinal detachment outcomes randomized trial (PIVOT)
    Shah, Serena
    Chou, Brandon
    Patel, Marissa
    Watane, Arjun
    Shah, Lea
    Yannuzzi, Nicolas
    Sridhar, Jayanth
    CURRENT OPINION IN OPHTHALMOLOGY, 2024, 35 (03) : 217 - 222